Triplet Therapy Slows Refractory Multiple Myeloma
WEDNESDAY, Nov. 18, 2020 — A once-weekly regimen of selinexor, bortezomib, and dexamethasone slows the progression of relapsed or refractory
Read moreWEDNESDAY, Nov. 18, 2020 — A once-weekly regimen of selinexor, bortezomib, and dexamethasone slows the progression of relapsed or refractory
Read more